Klaria Annual Report 2021 - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

Klaria Annual Report 2021

Summary of the year

- Net sales amounted to 0.0 MSEK (0.0 MSEK)

- Other operating income amounted to 37.5 MSEK (8.0 MSEK)

- R&D costs amounted to 63.5 MSEK (48.4 MSEK)

- Profit/loss after tax amounted to -53.5 MSEK (-51.4 MSEK)

- Earnings per share amounted to -1.03 SEK (-1.19 SEK)

- Cash flow from operations amounted to -24.8 MSEK (-35.3 MSEK)

- Shareholder’s equity as of December 31, 2021 amounted to 69.4 MSEK (109.6 MSEK)

- Cash and cash equivalents as of December 31, 2021 amounted to 25.5 MSEK (31.3 MSEK)

Bifogade filer

Nyheter om Klaria Pharma

Läses av andra just nu

Om aktien Klaria Pharma

Senaste nytt